600713 南京医药
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.4018.9128.5989.29311.232
总资产报酬率 ROA (%)0.5222.0121.9321.9242.071
投入资产回报率 ROIC (%)0.9483.5873.3413.7884.160

边际利润分析
销售毛利率 (%)6.2806.1546.2826.1836.490
营业利润率 (%)2.0562.1111.9061.8801.860
息税前利润/营业总收入 (%)2.8062.9462.8292.8232.671
净利润/营业总收入 (%)1.5291.5151.3841.3301.426

收益指标分析
经营活动净收益/利润总额(%)120.17789.973104.12596.540114.275
价值变动净收益/利润总额(%)-0.4380.4390.4000.877-5.369
营业外收支净额/利润总额(%)-0.980-0.214-1.994-3.003-3.125

偿债能力分析
流动比率 (X)1.4471.5341.6271.4011.313
速动比率 (X)1.1311.1611.2591.0891.053
资产负债率 (%)76.16373.74274.61074.46478.848
带息债务/全部投入资本 (%)61.65052.95760.54955.94856.498
股东权益/带息债务 (%)58.27082.93461.10873.36471.618
股东权益/负债合计 (%)27.20931.00029.87930.41924.042
利息保障倍数 (X)3.6473.5072.9462.8293.082

营运能力分析
应收账款周转天数 (天)95.66381.40579.61987.57190.106
存货周转天数 (天)48.56446.02843.22341.47839.498